Federal Register of Legislation - Australian Government

Primary content

PB 33 of 2012 Lists as made
This instrument amends the National Health (Listing of Pharmaceutical Benefits) Instrument 2010 (No. PB 108 of 2010) to provide for additions, deletions and changes to drugs, forms, brands, responsible person codes, and the circumstances for prescribing various pharmaceutical benefits (including authority requirements).
Administered by: Health
Registered 08 May 2012
Tabling HistoryDate
Tabled HR21-May-2012
Tabled Senate18-Jun-2012
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

PB 33 of 2012

National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2012
(No.4)
1

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under sections 84AF, 85, 85A, 88 and 101 of the National Health Act 1953.

Dated 4 May 2012

 

 

 

 

 

 

 

 

 

 

 

FELICITY McNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing


 


1          Name of Instrument

            (1)        This Instrument is the National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2012 (No. 4).

            (2)        This Instrument may also be cited as PB 33 of 2012.

2          Commencement

            This Instrument commences on 1 June 2012.

3          Amendment of the National Health (Listing of Pharmaceutical Benefits) Instrument 2010 (PB 108 of 2010)

            Schedule 1 amends the National Health (Listing of Pharmaceutical Benefits) Instrument 2010 (PB 108 of 2010).



Schedule 1     Amendments

 

[1]           Schedule 1, entry for Amlodipine with Atorvastatin

substitute:

Amlodipine with Atorvastatin

Tablet 5 mg amlodipine (as besylate) with 10 mg atorvastatin (as calcium)

Oral

Cadatin 5/10

FZ

MP NP

C2449 C2450 C2451

 

30

5

 

 

 

 

Caduet 5/10

PF

MP NP

C2449 C2450 C2451

 

30

5

 

 

Tablet 5 mg amlodipine (as besylate) with 20 mg atorvastatin (as calcium)

Oral

Cadatin 5/20

FZ

MP NP

C2449 C2450 C2451

 

30

5

 

 

 

 

Caduet 5/20

PF

MP NP

C2449 C2450 C2451

 

30

5

 

 

Tablet 5 mg amlodipine (as besylate) with 40 mg atorvastatin (as calcium)

Oral

Cadatin 5/40

FZ

MP NP

C2449 C2450 C2451

 

30

5

 

 

 

 

Caduet 5/40

PF

MP NP

C2449 C2450 C2451

 

30

5

 

 

Tablet 5 mg amlodipine (as besylate) with 80 mg atorvastatin (as calcium)

Oral

Cadatin 5/80

FZ

MP NP

C2449 C2450 C2451

 

30

5

 

 

 

 

Caduet 5/80

PF

MP NP

C2449 C2450 C2451

 

30

5

 

 

Tablet 10 mg amlodipine (as besylate) with 10 mg atorvastatin (as calcium)

Oral

Cadatin 10/10

FZ

MP NP

C2449 C2450 C2451

 

30

5

 

 

 

 

Caduet 10/10

PF

MP NP

C2449 C2450 C2451

 

30

5

 

 

Tablet 10 mg amlodipine (as besylate) with 20 mg atorvastatin (as calcium)

Oral

Cadatin 10/20

FZ

MP NP

C2449 C2450 C2451

 

30

5

 

 

 

 

Caduet 10/20

PF

MP NP

C2449 C2450 C2451

 

30

5

 

 

Tablet 10 mg amlodipine (as besylate) with 40 mg atorvastatin (as calcium)

Oral

Cadatin 10/40

FZ

MP NP

C2449 C2450 C2451

 

30

5

 

 

 

 

Caduet 10/40

PF

MP NP

C2449 C2450 C2451

 

30

5

 

 

Tablet 10 mg amlodipine (as besylate) with 80 mg atorvastatin (as calcium)

Oral

Cadatin 10/80

FZ

MP NP

C2449 C2450 C2451

 

30

5

 

 

 

 

Caduet 10/80

PF

MP NP

C2449 C2450 C2451

 

30

5

 

[2]           Schedule 1, entry for Amoxycillin

omit:

 

Sachet containing oral powder 3 g (as trihydrate)

Oral

Amoxil

GK

MP NP PDP

 

 

1

0

 

[3]           Schedule 1, entry for Anastrozole in the form Tablet 1 mg

omit:

 

 

 

Anastrozole LW

TA

MP NP

C2213

 

30

5

 

[4]           Schedule 1, entry for Atorvastatin

substitute:

Atorvastatin

Tablet 10 mg (as calcium)

Oral

APO-Atorvastatin

TX

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvachol

GM

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvastatin GH

GQ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvastatin Pfizer

FZ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvastatin Sandoz

SZ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Chem mart Atorvastatin

CH

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Lipitor

PF

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Lorstat 10

AF

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Terry White Chemists Atorvastatin

TW

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Torvastat 10

QA

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Trovas

RA

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

APO-Atorvastatin

TX

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvachol

GM

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvastatin GH

GQ

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvastatin Pfizer

FZ

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvastatin Sandoz

SZ

MP

C1540 C3047

P3047

30

11

 

 

 

 

Chem mart Atorvastatin

CH

MP

C1540 C3047

P3047

30

11

 

 

 

 

Lipitor

PF

MP

C1540 C3047

P3047

30

11

 

 

 

 

Lorstat 10

AF

MP

C1540 C3047

P3047

30

11

 

 

 

 

Terry White Chemists Atorvastatin

TW

MP

C1540 C3047

P3047

30

11

 

 

 

 

Torvastat 10

QA

MP

C1540 C3047

P3047

30

11

 

 

 

 

Trovas

RA

MP

C1540 C3047

P3047

30

11

 

 

Tablet 20 mg (as calcium)

Oral

APO-Atorvastatin

TX

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvachol

GM

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvastatin GH

GQ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvastatin Pfizer

FZ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvastatin Sandoz

SZ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Chem mart Atorvastatin

CH

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Lipitor

PF

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Lorstat 20

AF

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Terry White Chemists Atorvastatin

TW

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Torvastat 20

QA

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Trovas

RA

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

APO-Atorvastatin

TX

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvachol

GM

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvastatin GH

GQ

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvastatin Pfizer

FZ

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvastatin Sandoz

SZ

MP

C1540 C3047

P3047

30

11

 

 

 

 

Chem mart Atorvastatin

CH

MP

C1540 C3047

P3047

30

11

 

 

 

 

Lipitor

PF

MP

C1540 C3047

P3047

30

11

 

 

 

 

Lorstat 20

AF

MP

C1540 C3047

P3047

30

11

 

 

 

 

Terry White Chemists Atorvastatin

TW

MP

C1540 C3047

P3047

30

11

 

 

 

 

Torvastat 20

QA

MP

C1540 C3047

P3047

30

11

 

 

 

 

Trovas

RA

MP

C1540 C3047

P3047

30

11

 

 

Tablet 40 mg (as calcium)

Oral

APO-Atorvastatin

TX

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvachol

GM

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvastatin GH

GQ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvastatin Pfizer

FZ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvastatin Sandoz

SZ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Chem mart Atorvastatin

CH

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Lipitor

PF

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Lorstat 40

AF

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Terry White Chemists Atorvastatin

TW

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Torvastat 40

QA

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Trovas

RA

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

APO-Atorvastatin

TX

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvachol

GM

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvastatin GH

GQ

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvastatin Pfizer

FZ

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvastatin Sandoz

SZ

MP

C1540 C3047

P3047

30

11

 

 

 

 

Chem mart Atorvastatin

CH

MP

C1540 C3047

P3047

30

11

 

 

 

 

Lipitor

PF

MP

C1540 C3047

P3047

30

11

 

 

 

 

Lorstat 40

AF

MP

C1540 C3047

P3047

30

11

 

 

 

 

Terry White Chemists Atorvastatin

TW

MP

C1540 C3047

P3047

30

11

 

 

 

 

Torvastat 40

QA

MP

C1540 C3047

P3047

30

11

 

 

 

 

Trovas

RA

MP

C1540 C3047

P3047

30

11

 

 

Tablet 80 mg (as calcium)

Oral

APO-Atorvastatin

TX

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvachol

GM

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvastatin GH

GQ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvastatin Pfizer

FZ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Atorvastatin Sandoz

SZ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Chem mart Atorvastatin

CH

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Lipitor

PF

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Lorstat 80

AF

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Terry White Chemists Atorvastatin

TW

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Torvastat 80

QA

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

Trovas

RA

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

 

 

 

APO-Atorvastatin

TX

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvachol

GM

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvastatin GH

GQ

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvastatin Pfizer

FZ

MP

C1540 C3047

P3047

30

11

 

 

 

 

Atorvastatin Sandoz

SZ

MP

C1540 C3047

P3047

30

11

 

 

 

 

Chem mart Atorvastatin

CH

MP

C1540 C3047

P3047

30

11

 

 

 

 

Lipitor

PF

MP

C1540 C3047

P3047

30

11

 

 

 

 

Lorstat 80

AF

MP

C1540 C3047

P3047

30

11

 

 

 

 

Terry White Chemists Atorvastatin

TW

MP

C1540 C3047

P3047

30

11

 

 

 

 

Torvastat 80

QA

MP

C1540 C3047

P3047

30

11

 

 

 

 

Trovas

RA

MP

C1540 C3047

P3047

30

11

 

[5]           Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 2.5 mg

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Biso 2.5

WQ

MP NP

C3234

 

28

5

 

[6]           Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 5 mg

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Biso 5

WQ

MP NP

C3234

 

28

5

 

[7]           Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 10 mg

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Biso 10

WQ

MP NP

C3234

 

28

5

 


[8]           Schedule 1, entry for Carvedilol in the form Tablet 3.125 mg

(a)        omit:

 

 

 

Dilasig 3.125

FM

MP NP

C1735 C3234

 

30

0

 

(b)           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Volirop 3.125

DO

MP NP

C1735 C3234

 

30

0

 

[9]           Schedule 1, entry for Carvedilol in the form Tablet 6.25 mg

(a)        omit:

 

 

 

Dilasig 6.25

FM

MP NP

C1735 C3234

 

60

5

 

(b)           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Volirop 6.25

DO

MP NP

C1735 C3234

 

60

5

 

[10]         Schedule 1, entry for Carvedilol in the form Tablet 12.5 mg

(a)        omit:

 

 

 

Dilasig 12.5

FM

MP NP

C1735 C3234

 

60

5

 

(b)           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Volirop 12.5

DO

MP NP

C1735 C3234

 

60

5

 

[11]         Schedule 1, entry for Carvedilol in the form Tablet 25 mg

(a)        omit:

 

 

 

Dilasig 25

FM

MP NP

C1735 C3234

 

60

5

 

(b)           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Volirop 25

DO

MP NP

C1735 C3234

 

60

5

 

[12]         Schedule 1, entry for Cephazolin in each of the forms: Powder for injection 500 mg (as sodium); and Powder for injection 1 g (as sodium)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Cefazolin-AFT

AE

MP NP

C1169 C1846 C1847 C3132

 

10

0

 

[13]         Schedule 1, entry for Diltiazem in the form Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg

(a)        omit from the column headed “Responsible Person” for the brand “Diltahexal CD”:                        SZ          substitute:                HX

(b)           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Diltiazem Sandoz CD

SZ

MP NP

 

 

30

5

 

[14]         Schedule 1, entry for Fluconazole

omit:

 

 

 

Fluzole 50

QA

MP NP

C3613 C3614 C3615 C3616 C3617 C3618

 

28

5

 

[15]         Schedule 1, entry for Fosinopril in each of the forms: Tablet containing fosinopril sodium 10 mg; and Tablet containing fosinopril sodium 20 mg

omit:

 

 

 

Fosinopril Sandoz

SZ

MP NP

 

 

30

5

 

[16]         Schedule 1, entry for Fosinopril with Hydrochlorothiazide in the form Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg

omit:

 

 

 

Fosinopril/HCT Sandoz 10mg/12.5mg

SZ

MP NP

C3307

 

30

5

 

[17]         Schedule 1, entry for Fosinopril with Hydrochlorothiazide in the form Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg

omit:

 

 

 

Fosinopril/HCT Sandoz 20mg/12.5mg

SZ

MP NP

C3307

 

30

5

 

[18]         Schedule 1, entry for Gemcitabine in each of the forms: Powder for I.V. infusion 200 mg (as hydrochloride); and Powder for I.V. infusion 1 g (as hydrochloride)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Gemaccord

WQ

MP

 

 

See Note 3

See Note 3

D

[19]         Schedule 1, after entry for Glucose Indicator—Blood in the form Test strips, 100 (Accu-Chek Performa)

insert:

 

Test strips, 100 (Contour)

For external use

Contour

IK

MP NP

 

 

1

5

 

 

 

 

 

 

MP

 

P3035

1

11

 

[20]         Schedule 1, entry for Irinotecan in each of the forms: I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL; and
I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Irinoccord

WQ

MP

C3184

 

See Note 3

See Note 3

D

[21]         Schedule 1, entry for Lamotrigine in the form Tablet 25 mg

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Torlemo DT 25

TA

MP NP

C1426

 

56

5

 

[22]         Schedule 1, entry for Lamotrigine in the form Tablet 50 mg

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Torlemo DT 50

TA

MP NP

C1426

 

56

5

 

[23]         Schedule 1, entry for Lamotrigine in the form Tablet 100 mg

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Torlemo DT 100

TA

MP NP

C1426

 

56

5

 

[24]         Schedule 1, entry for Lamotrigine in the form Tablet 200 mg

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Torlemo DT 200

TA

MP NP

C1426

 

56

5

 

[25]         Schedule 1, entry for Mycophenolic Acid in the form Capsule containing mycophenolate mofetil 250 mg [Max Quantity 300; Number of Repeats 3]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Pharmacor Mycophenolate 250

CR

MP

C1765 C1766

 

300

3

 

[26]         Schedule 1, entry for Mycophenolic Acid in the form Capsule containing mycophenolate mofetil 250 mg [Max Quantity 600; Number of Repeats 5]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Pharmacor Mycophenolate 250

CR

MP
See Note 1

C1650 C1651 C3355 C3356

 

600

5

C

[27]         Schedule 1, entry for Oxaliplatin in each of the forms: Solution concentrate for I.V. infusion 50 mg in 10 mL; and Solution concentrate for I.V. infusion 100 mg in 20 mL

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Oxaliccord

WQ

MP

C3900 C3901 C3930 C3939

 

See Note 3

See Note 3

D

[28]         Schedule 1, entry for Paroxetine in the form Tablet 20 mg (as hydrochloride)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Roxet 20

DO

MP NP

C1211 C1241 C1862

 

30

5

 

[29]         Schedule 1, entry for Paroxetine in the form Tablet 20 mg (as mesilate)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Paroxetine Synthon

ZT

MP NP

C1211 C1241 C1862

 

30

5

 

[30]         Schedule 1, entry for Simvastatin in the form Tablet 5 mg [Max Quantity 30; Number of Repeats 5]

(a)        omit from the column headed “Responsible Person” for the brand “Simvahexal”:                             SZ          substitute:                HX

(b)           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Simvastatin Sandoz

SZ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

[31]         Schedule 1, entry for Simvastatin in the form Tablet 5 mg [Max Quantity 30; Number of Repeats 11]

(a)        omit from the column headed “Responsible Person” for the brand “Simvahexal”:                             SZ          substitute:                HX

(b)           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Simvastatin Sandoz

SZ

MP

C1540 C3047

P3047

30

11

 

[32]         Schedule 1, entry for Simvastatin in the form Tablet 10 mg [Max Quantity 30; Number of Repeats 5]

(a)        omit from the column headed “Responsible Person” for the brand “Simvahexal”:                             SZ          substitute:                HX

(b)           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Simvastatin Sandoz

SZ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

[33]         Schedule 1, entry for Simvastatin in the form Tablet 10 mg [Max Quantity 30; Number of Repeats 11]

(a)        omit from the column headed “Responsible Person” for the brand “Simvahexal”:                             SZ          substitute:                HX

(b)           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Simvastatin Sandoz

SZ

MP

C1540 C3047

P3047

30

11

 

[34]         Schedule 1, entry for Simvastatin in the form Tablet 20 mg [Max Quantity 30; Number of Repeats 5]

(a)        omit from the column headed “Responsible Person” for the brand “Simvahexal”:                             SZ          substitute:                HX

(b)           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Simvastatin Sandoz

SZ

MP

C1540 C3047

P1540

30

5

 

 

 

 

 

 

NP

C1540

 

30

5

 

[35]         Schedule 1, entry for Simvastatin in the form Tablet 20 mg [Max Quantity 30; Number of Repeats 11]

(a)        omit from the column headed “Responsible Person” for the brand “Simvahexal”:                             SZ          substitute:                HX

(b)           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Simvastatin Sandoz

SZ

MP

C1540 C3047

P3047

30

11

 

[36]         Schedule 1, after entry for Tenofovir with emtricitabine and efavirenz

insert:

Tenofovir with Emtricitabine and Rilpivirine

Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg and rilpivirine 25 mg (as hydrochloride)

Oral

Eviplera

GI

MP
See Note 1

C3983 C3984 C3985 C3986

 

60

5

D

[37]         Schedule 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Max Quantity 20; Number of Repeats 0]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Valaciclovir Pfizer

FZ

MP NP

C3622 C3623 C3624 C3631 C3632

P3632

20

0

 

[38]         Schedule 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Max Quantity 30; Number of Repeats 5]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Valaciclovir Pfizer

FZ

MP NP

C3622 C3623 C3624 C3631 C3632

P3623 P3624

30

5

 

[39]         Schedule 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Max Quantity 42; Number of Repeats 0]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

Valaciclovir Pfizer

FZ

MP NP

C3622 C3623 C3624 C3631 C3632

P3622 P3631

42

0

 

[40]         Schedule 3, after details relevant to Responsible person code IA

insert:

IK

Medtronic Australasia Pty Ltd

47 001 162 661


[41]         Schedule 4, Part 1, after entry for Tenofovir with emtricitabine and efavirenz

insert:

Tenofovir with Emtricitabine and Rilpivirine

C3983

 

Where the patient is receiving treatment at/from a private hospital

Initial treatment of human immunodeficiency virus (HIV) infection in a patient with a CD4 count of less than 500 per cubic millimetre or symptomatic HIV disease

Compliance with Written or Telephone Authority Required procedures

 

C3984

 

Where the patient is receiving treatment at/from a private hospital

Continuing treatment of human immunodeficiency virus (HIV) infection where the patient has previously received PBS-subsidised therapy for HIV infection

Compliance with Written or Telephone Authority Required procedures

 

C3985

 

Where the patient is receiving treatment at/from a public hospital

Initial treatment of human immunodeficiency virus (HIV) infection in a patient with a CD4 count of less than 500 per cubic millimetre or symptomatic HIV disease

Compliance with Written or Telephone Authority Required procedures Streamlined Authority Code 3985

 

C3986

 

Where the patient is receiving treatment at/from a public hospital

Continuing treatment of human immunodeficiency virus (HIV) infection where the patient has previously received PBS-subsidised therapy for HIV infection

Compliance with Written or Telephone Authority Required procedures - Streamlined Authority Code 3986

1

 

 

Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 

See http://www.frli.gov.au.